LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Lung Cancer Screen 44 Tissue Microarray - LS-SLUCA44

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SLUCA44
Product Name: Lung Cancer Screen 44
Description: Lung cancer with stage/grade and adjacent normal/non-neoplastic lung
Format: FFPE
Category: Human Tumor and Adjacent Normal
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 24
Cores: 72
Slides Per Set: 1

LS-SLUCA44 Tissue Microarray Map

Slide Number 1
LABEL
 123456789
ALngLngLngLngLngLngLngLngLng
BLngLngLngLngLngLngLngLngLng
CLngLngLngLngLngLngLngLngLng
DLngLngLngLngLngLngLngLngLng
ELngLngLngLngLngLngLngLngLng
FLngLngLngLngLngLngLngLngLng
GLngLngLngLngLngLngLngLngLng
HLngLngLngLngLngLngLngLngLng
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Lung (Lng);

LS-SLUCA44 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor Grade
1A1HumanM42 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1A2HumanM42 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1A3HumanM42 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1A4HumanM70 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1A5HumanM70 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1A6HumanM70 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1A7HumanF54 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1A8HumanF54 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1A9HumanF54 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B1HumanM61 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B2HumanM61 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B3HumanM61 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B4HumanM55 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B5HumanM55 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B6HumanM55 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B7HumanF63 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B8HumanF63 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1B9HumanF63 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1C1HumanM68 yLung (Lng)AdenocarcinomaMalignantT3N0M02
1C2HumanM68 yLung (Lng)AdenocarcinomaMalignantT3N0M02
1C3HumanM68 yLung (Lng)Adenocarcinoma with chronic inflammationMalignantT3N0M0
1C4HumanM49 yLung (Lng)AdenocarcinomaMalignantT3N0M02
1C5HumanM49 yLung (Lng)AdenocarcinomaMalignantT3N0M02
1C6HumanM49 yLung (Lng)AdenocarcinomaMalignantT3N0M02
1C7HumanM58 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1C8HumanM58 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1C9HumanM58 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1D1HumanM69 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D2HumanM69 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D3HumanM69 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D4HumanF59 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D5HumanF59 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D6HumanF59 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D7HumanM54 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D8HumanM54 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1D9HumanM54 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E1HumanF61 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1E2HumanF61 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1E3HumanF61 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1E4HumanF58 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E5HumanF58 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E6HumanF58 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E7HumanM51 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E8HumanM51 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1E9HumanM51 yLung (Lng)AdenocarcinomaMalignantT3N1M02
1F1HumanM70 yLung (Lng)Adenocarcinoma, PapillaryMalignantT2N0M02
1F2HumanM70 yLung (Lng)Adenocarcinoma, PapillaryMalignantT2N0M02
1F3HumanM70 yLung (Lng)Adenocarcinoma, PapillaryMalignantT2N0M02
1F4HumanF56 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1F5HumanF56 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1F6HumanF56 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1F7HumanM49 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1F8HumanM49 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1F9HumanM49 yLung (Lng)AdenocarcinomaMalignantT2N1M02
1G1HumanM47 yLung (Lng)AdenocarcinomaMalignantT4N0M02
1G2HumanM47 yLung (Lng)AdenocarcinomaMalignantT4N0M02
1G3HumanM47 yLung (Lng)AdenocarcinomaMalignantT4N0M02
1G4HumanM53 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1G5HumanM53 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1G6HumanM53 yLung (Lng)AdenocarcinomaMalignantT2N0M02
1G7HumanF50 yLung (Lng)AdenocarcinomaMalignantT1N0M02
1G8HumanF50 yLung (Lng)AdenocarcinomaMalignantT1N0M02
1G9HumanF50 yLung (Lng)AdenocarcinomaMalignantT1N0M02
1H1HumanF58 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H2HumanF58 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H3HumanF58 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H4HumanM45 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H5HumanM45 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H6HumanM45 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H7HumanM66 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H8HumanM66 yLung (Lng)Adjacent normalBenign non-neoplastic  
1H9HumanM66 yLung (Lng)Adjacent normalBenign non-neoplastic  
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved